Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2019 16:01 ET | Source: ChromaDex Corporation

ChromaDex Corporation Reports 2018 Financial Results

- Full Year 2018 Net Revenues Increased by 49% to $31.6 Million and Fourth Quarter 2018 Net Revenues Increased by 20% to $9.1 Million - Fourth Quarter 2018 Highlights vs. Fourth Quarter 2017 ...
March 01, 2019 06:30 ET | Source: ChromaDex Corporation

ChromaDex to Present at the 39th Annual Cowen Health Care Conference

LOS ANGELES, March 01, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will present at...
February 28, 2019 06:30 ET | Source: ChromaDex Corporation

ChromaDex to Report Fourth Quarter 2018 Financial Results on Thursday, March 7, 2019

LOS ANGELES, Feb. 28, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs., Mar. 7, 2019 at 4:30 p.m. Eastern time to discuss its financial...
January 23, 2019 06:30 ET | Source: ChromaDex Corporation

New Study Shows Supplementation with Nicotinamide Riboside (NR) During Breastfeeding Yields Measurable, Lasting Benefits to Mothers and Offspring in Animal Model

LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today reported that results of a first-of-a-kind preclinical study on lactation have shown that supplementation with the...
January 22, 2019 16:05 ET | Source: ChromaDex Corporation

ChromaDex Prepared to Proceed with Patent Infringement Action Against Elysium Health

LOS ANGELES, Jan. 22, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today reported the rejection of Elysium Health Inc.’s challenge to Claim 2 of U.S. Patent No. 8,383,086 ("the '086...
December 20, 2018 16:05 ET | Source: ChromaDex Corporation

ChromaDex Corp. and Nestlé Health Science Enter Global Commercial License and Supply Agreement for TRU NIAGEN®

LOS ANGELES, Dec. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today it entered into a license and supply agreement with Nestlé Health Science (NHSc), a global leader...
December 17, 2018 06:30 ET | Source: ChromaDex Corporation

TRU NIAGEN® Expands North American Footprint with Product Launch in Canada

LOS ANGELES, Dec. 17, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today it has officially launched TRU NIAGEN® in Canada, having received regulatory approval for sale by Health...
December 12, 2018 06:30 ET | Source: ChromaDex Corporation

TRU NIAGEN® to be Featured at the American Academy of Anti-Aging Medicine Annual Meeting

LOS ANGELES, Dec. 12, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today it will feature TRU NIAGEN® (Booth #6095) at the American Academy of Anti-Aging Medicine World Congress,...
November 28, 2018 06:30 ET | Source: ChromaDex Corporation

ChromaDex to Present at the 11th Annual LD Micro Main Event

LOS ANGELES, Nov. 28, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, Co-Founder & Executive Chairman, Frank Jaksch, and Chief...
November 20, 2018 06:30 ET | Source: ChromaDex Corporation

New TRU NIAGEN® Stick Packs Target New Audiences and Consumer Needs

LOS ANGELES, Nov. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today the launch of TRU NIAGEN stick packs, offering a new delivery method of its revolutionary nicotinamide...